| Drug Name |
Pentamidine isethionate |
| Drug ID |
BADD_D01718 |
| Description |
Antiprotozoal agent effective in trypanosomiasis, leishmaniasis, and some fungal infections; used in treatment of pneumocystis pneumonia in HIV-infected patients. It may cause diabetes mellitus, central nervous system damage, and other toxic effects. |
| Indications and Usage |
For the treatment of pneumonia due to Pneumocystis carinii. |
| Marketing Status |
approved; investigational |
| ATC Code |
P01CX01 |
| DrugBank ID |
DB00738
|
| KEGG ID |
D00834
|
| MeSH ID |
D010419
|
| PubChem ID |
8813
|
| TTD Drug ID |
D05EAM
|
| NDC Product Code |
14593-930; 23155-748; 11712-790; 14593-940; 39822-3050; 39822-3030; 63323-113; 11712-788; 13925-515; 63323-877; 13925-522 |
| UNII |
V2P3K60DA2
|
| Synonyms |
Pentamidine | Pentamidin | Lomidine | NebuPent | Pentamidine Isethionate | Pentam | Pentamidine Mesylate | Diamidine | Pentacarinat |